Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
24.43
+0.44 (1.83%)
At close: Nov 7, 2025, 4:00 PM EST
24.44
+0.01 (0.04%)
After-hours: Nov 7, 2025, 7:59 PM EST
Pfizer Stock Forecast
Stock Price Forecast
The 9 analysts that cover Pfizer stock have a consensus rating of "Hold" and an average price target of $27.44, which forecasts a 12.32% increase in the stock price over the next year. The lowest target is $24 and the highest is $32.
Price Target: $27.44 (+12.32%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Pfizer stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 3 | 3 | 2 | 2 | 1 | 0 |
| Hold | 9 | 9 | 8 | 8 | 8 | 7 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 15 | 13 | 13 | 12 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains $33 → $32 | Hold | Maintains | $33 → $32 | +30.99% | Oct 10, 2025 |
| B of A Securities | B of A Securities | Hold Maintains $28 → $30 | Hold | Maintains | $28 → $30 | +22.80% | Oct 3, 2025 |
| Citigroup | Citigroup | Hold Maintains $25 → $26 | Hold | Maintains | $25 → $26 | +6.43% | Aug 6, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $32 → $33 | Hold | Maintains | $32 → $33 | +35.08% | Aug 6, 2025 |
| B of A Securities | B of A Securities | Hold Maintains $27 → $28 | Hold | Maintains | $27 → $28 | +14.61% | Aug 6, 2025 |
Financial Forecast
Revenue This Year
63.51B
from 63.63B
Decreased by -0.19%
Revenue Next Year
63.07B
from 63.51B
Decreased by -0.68%
EPS This Year
3.07
from 1.41
Increased by 117.63%
EPS Next Year
3.17
from 3.07
Increased by 3.07%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 67.2B | 67.9B | |||
| Avg | 63.5B | 63.1B | |||
| Low | 60.2B | 57.2B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 5.7% | 7.0% | |||
| Avg | -0.2% | -0.7% | |||
| Low | -5.4% | -9.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.32 | 3.57 | |||
| Avg | 3.07 | 3.17 | |||
| Low | 2.83 | 2.90 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 135.0% | 16.2% | |||
| Avg | 117.6% | 3.1% | |||
| Low | 100.6% | -5.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.